MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41408-020-0319-0

Медицинская библиотека · Blood cancer journal · 2020

The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?

Sidiqi M Hasib, Aljama Mohammed, Kumar Shaji K, Jevremovic Dragan, Buadi Francis K, Warsame Rahma, Lacy Martha Q, Dingli David, Gonsalves Wilson I, Fonder Amie L, Hobbs Miriam A, Hwa Yi Lisa, Kapoor Prashant, Kourelis Taxiarchis, Leung Nelson, Muchtar Eli, Lust John A, Kyle Robert A, Go Ronald S, Rajkumar Vincent S, Gertz Morie A, Dispenzieri Angela

СтатьяПеревод в очереди

Аннотация

We conducted a retrospective review of multiple myeloma (MM), smoldering multiple myeloma (SMM), and monoclonal gammopathy of undetermined significance (MGUS) patients seen at Mayo Clinic to determine whether a bone marrow biopsy (BM) is necessary in all patients diagnosed with a monoclonal protein. A total of 2254 MM, 397 SMM, and 5836 MGUS patients were included in the study. A total of 29 (1.3%) MM patients "without CRAB/FLC" were identified where BM or advanced imaging was critical for diagnosis, 8 (0.3% MM cohort) of whom were diagnosed with MM solely on BM findings (plasma cells > 60%). Without BM or advanced imaging none of these patients would be classified low-risk MGUS. A total of 314 (79%) MGUS-like SMM patients were identified where classification of SMM was based on BM findings. Without BM 97 would be classified as low/low-intermediate-risk MGUS and 151 intermediate or high-risk MGUS; 66 had missing information precluding classification. Only three (<1% SMM cohort) were low-risk MGUS without abnormalities in hemoglobin, calcium, and renal function. In patients presenting with low-risk MGUS and normal hemoglobin, calcium, and renal function, the risk of missing a diagnosis of SMM and MM by omitting BM is <1%. BM should be deferred in these patients in preference to clinical and laboratory monitoring.

Для цитирования: Sidiqi M Hasib, Aljama Mohammed, Kumar Shaji K, Jevremovic Dragan, Buadi Francis K, Warsame Rahma, Lacy Martha Q, Dingli David, Gonsalves Wilson I, Fonder Amie L, Hobbs Miriam A, Hwa Yi Lisa, Kapoor Prashant, Kourelis Taxiarchis, Leung Nelson, Muchtar Eli, Lust John A, Kyle Robert A, Go Ronald S, Rajkumar Vincent S, Gertz Morie A, Dispenzieri Angela. The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?. Blood cancer journal. 2020. DOI: 10.1038/s41408-020-0319-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.